A real price, with its limits
Semaglutide is the medicine ingredient in some products used for diabetes or weight loss (product records checked September 26, 2026).
This example is for semaglutide sold as Ozempic injections. It shows how a starting price can change. This example does not quote a price for your own care.
The government price page listed a starting price of $199 for a month’s supply of semaglutide (Ozempic) injections when checked on September 26, 2026.
That price was for the first two monthly supplies only, for new patients paying without insurance who met the offer’s rules.
Here, strength tells you how much medicine each shot contains.
The rules required patients to be at least 18, live in the US and use one of the lower strengths covered by the offer.
After the starting offer, the listed monthly price was $349 for the lower listed strengths or $499 for the highest listed strength.
The entry offer runs through December 31, 2026.
Cash-pay means you pay for the medicine without using insurance.
Under this offer’s rules, you cannot ask insurance to pay you back for the medicine.
You also cannot count that payment towards your insurance deductible.
Source: Government price listing and offer termsA deductible is a set amount you pay first, before your plan shares covered costs.
The price record used for this example does not say how many shots are in a monthly supply. Ask for a quote naming the amount per shot, the number of shots supplied, whether you qualify for the offer, and your price after it ends.
Ask the service for the separate cost of visits and follow-up.